RxDoctor Payments Data

Mohammad Khasawneh

Vascular Surgery · Rochester, MNNPI 1770928780

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (32.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medtronic at 38.5% of the total. Reporting peaked in 2019 at $13,347 and has fallen 51.8% since, to $6,430 in 2025. Among vascular surgery clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,655in general payments, 2019–2025

Across 119 payments — averaging $249.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$11K
  • W. L. Gore & Associates, Inc.$4K
  • Shockwave Medical, Inc$4K
  • Abbott$4K
  • Cook Medical LLC$2K
  • Boston Scientific$1K
  • plus $2K from 7 others

What the payments were for

  • Consulting fees$8,58829%
  • Grants$9,76433%
  • Travel & lodging$4,11714%
  • Food & beverage$6,86523%
  • Education$3211%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,655 in reported general payments places this provider in the 90th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$105,818
Medicare patients
373
Services billed
776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban16$23,363
ClopidogrelClopidogrel Bisulfate113$2,222
Rosuvastatin Calcium20$267
Atorvastatin Calcium21$246

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →